Equities

Petmed Express Inc

Petmed Express Inc

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (USD)4.00
  • Today's Change-0.02 / -0.50%
  • Shares traded313.00
  • 1 Year change-70.91%
  • Beta0.7290
Data delayed at least 15 minutes, as of Jul 03 2024 18:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

PetMed Express, Inc., doing business as PetMeds, is a direct-to-consumer pet pharmacy. The Company is an online provider of prescription and non-prescription medications, food, supplements, and supplies and has veterinary and pet insurance service partnerships for dogs, cats, and horses. It markets and sells directly to consumers through their Websites, toll-free numbers, and employer benefit partnerships. Its product line contains over 15,000 SKUs of pet medications, health products, foods, and supplies. The Company offers various pet supplies, including beds, crates, stairs and other pet supplies. Its products include Prescription Medications (Rx), Non-Prescription Medications (OTC) and supplies, Pet Foods, Private Label and Holistic Wellness Services. Rx includes heartworm and flea and ticks preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.

  • Revenue in USD (TTM)281.06m
  • Net income in USD-7.46m
  • Incorporated1996
  • Employees287.00
  • Location
    Petmed Express Inc420 South Congress AvenueDELRAY BEACH 33445United StatesUSA
  • Phone+1 (561) 426-4444
  • Fax+1 (800) 600-8285
  • Websitehttps://www.1800petmeds.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Maison Solutions Inc55.30m-231.24k25.99m175.00--1.9688.060.47-0.0106-0.01063.020.67421.4814.4247.22317,821.00-0.1604---0.2006--22.55---0.1081--1.76-2.000.1619--31.95--322.45------
REST EZ Inc0.00-433.38k27.54m-----------21.61-21.610.00-0.00210.000.00-----211.26---458.82----------0.00-2.36-----100.00---349.29------
Davis Commodities Ltd190.72m1.09m27.93m22.0025.722.7224.330.14650.04430.04437.990.41877.9831.1919.158,669,273.004.55--12.58--3.69--0.5694--0.873610.430.0605---7.74---76.47------
Willcox International Holdings Inc16.69m26.05k69.45m120.00849.061.4538.444.160.00050.00050.33380.31050.7509----139,051.407.81--11.22--42.85--10.40------0.00--7.13--125.53------
Petmed Express Inc281.06m-7.46m82.43m287.00--0.8746--0.2933-0.3652-0.365213.784.571.678.51111.91979,317.10-4.428.58-7.1911.3227.9828.33-2.665.190.9021--0.00147.049.54-0.1667-245.21--48.72-10.76
AMCON Distributing Co2.64bn8.51m93.82m1.28k10.510.86915.300.035614.1614.164,369.63171.258.0319.4739.712,065,712.002.594.373.585.786.846.250.32290.51461.022.410.50803.9126.3213.95-30.4532.5329.080.00
G Willi-Food International Ltd141.39m10.54m125.03m207.0011.860.832210.030.88430.76020.760210.2010.830.85324.843.18683,032.806.367.567.058.1421.8228.627.469.479.14--0.005942.729.029.94-23.844.8661.50--
Hf Foods Group Inc1.15bn3.07m149.94m925.0050.480.51855.240.13040.05650.056521.485.501.898.5124.551,243,559.000.4235-11.060.5634-14.0717.7617.800.2239-7.770.48841.970.3909---1.8831.60-572.61--2.70--
Village Super Market, Inc.2.21bn48.44m391.75m2.17k9.330.89814.570.17712.842.84126.3929.502.3133.9488.611,019,417.005.263.726.384.5528.6328.072.271.510.8215--0.18245.665.126.0984.7315.135.520.00
Data as of Jul 03 2024. Currency figures normalised to Petmed Express Inc's reporting currency: US Dollar USD

Institutional shareholders

42.26%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 31 Mar 20241.63m7.70%
Renaissance Technologies LLCas of 31 Mar 20241.58m7.48%
The Vanguard Group, Inc.as of 31 Mar 20241.17m5.53%
Hotchkis & Wiley Capital Management LLCas of 31 Mar 20241.06m5.00%
Global X Management Co. LLCas of 31 Mar 2024700.92k3.31%
AQR Capital Management LLCas of 31 Mar 2024683.03k3.23%
Arrowstreet Capital LPas of 31 Mar 2024563.89k2.67%
Numeric Investors LLCas of 31 Mar 2024547.00k2.59%
Charles Schwab Investment Management, Inc.as of 31 Mar 2024522.97k2.47%
Geode Capital Management LLCas of 31 Mar 2024483.35k2.29%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.